Literature DB >> 2440012

[Therapy of atopic dermatitis in children. Study on the use of a desensitizing preparation].

A Paci, G Taddeucci-Brunelli, P Barachini, P Magliaccio, G Pierini, G Crimaldi.   

Abstract

Children with Atopic Dermatitis have been treated with Histaglobin (gamma globulin + histamine) applied by hypodermic injections. The patients (42) were divided into three groups: the first one (ten cases) aged between 9 and 5 years; the second one (eight cases) between 5 and 2 years and the third one (twenty four cases) aged less than two years. The trial has been carried out in two phases: the first one consisted of nine injections with increasing doses ranging from 1/3 to 1 ampoule with 4-6 day intervals; the second one, "the maintenance period", was made by nine injections of 1 ampoule with increasing intervals from two up to four weeks. The following four parameters were checked along all the therapy period: prurigo, erythema, exudation, scratching lesions. All the listed symptoms have been observed to decrease of intensity mainly during the first phase, until the complete disappearance of some of them; the residual symptoms continued to have a further improvement during the second phase; in most case disappeared completely. Absolutely no troubles of any kind have been noticed. Consequently the Authors consider the desensitization therapy by Histaglobin on the whole satisfying.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2440012

Source DB:  PubMed          Journal:  Pediatr Med Chir        ISSN: 0391-5387


  3 in total

1.  Improved HPLC Method Using 2,3-naphthalenedicarboxaldehyde as Fluorescent Labeling Agent for Quantification of Histamine in Human Immunoglobulin Preparations.

Authors:  Jung-Hwan Kim; In Soo Shin; Yoo Kyoung Lee; Ho Jung Oh; Sang Ja Ban
Journal:  Osong Public Health Res Perspect       Date:  2011-07-29

Review 2.  Next-Generation of Allergen-Specific Immunotherapies: Molecular Approaches.

Authors:  Mirela Curin; Musa Khaitov; Alexander Karaulov; Leyla Namazova-Baranova; Raffaela Campana; Victoria Garib; Rudolf Valenta
Journal:  Curr Allergy Asthma Rep       Date:  2018-06-09       Impact factor: 4.806

3.  Immunotherapy using Histobulin in atopic dermatitis.

Authors:  Geunwoong Noh
Journal:  Clin Case Rep       Date:  2020-11-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.